IRIS - Res&Arch Institutional Research Information System - Research & Archive

LUDOVINI, VIENNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.085
AS - Asia 848
EU - Europa 683
SA - Sud America 151
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 25
OC - Oceania 1
Totale 2.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.037
SG - Singapore 398
IT - Italia 182
BR - Brasile 123
CN - Cina 122
IE - Irlanda 120
HK - Hong Kong 97
VN - Vietnam 88
RU - Federazione Russa 82
DE - Germania 79
FR - Francia 52
FI - Finlandia 34
SE - Svezia 31
GB - Regno Unito 25
KR - Corea 25
BD - Bangladesh 22
CA - Canada 19
IN - India 19
MX - Messico 19
AR - Argentina 12
IQ - Iraq 12
AT - Austria 11
PL - Polonia 11
ZA - Sudafrica 11
TR - Turchia 10
JP - Giappone 9
RO - Romania 9
ES - Italia 8
PK - Pakistan 8
UA - Ucraina 8
NL - Olanda 7
CH - Svizzera 6
JO - Giordania 6
MA - Marocco 6
ID - Indonesia 5
BO - Bolivia 4
PY - Paraguay 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
GR - Grecia 3
MY - Malesia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
MT - Malta 2
OM - Oman 2
PH - Filippine 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GN - Guinea 1
IR - Iran 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
PW - Palau 1
RE - Reunion 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 2.794
Salva come PNG Salva come JPEG
Città #
Singapore 309
Chandler 168
San Jose 123
Dublin 120
Hong Kong 97
Perugia 85
Ashburn 78
Munich 52
Boardman 47
Santa Clara 42
San Mateo 37
Beijing 34
Moscow 28
Dong Ket 25
Seoul 24
The Dalles 24
Altamura 22
Ho Chi Minh City 22
Lauterbourg 22
Ann Arbor 21
Helsinki 21
Medford 21
Princeton 21
Los Angeles 20
Lawrence 18
New York 18
Andover 15
Redmond 14
Mexico City 13
São Paulo 13
Hanoi 12
Piscataway 11
Warsaw 11
Bucharest 9
Dearborn 9
Montreal 9
Frankfurt am Main 8
Johannesburg 8
Tokyo 8
Chennai 7
Nuremberg 7
Vienna 7
Atlanta 6
Chicago 6
Dallas 6
Houston 6
Rome 6
Saint Petersburg 6
San Paolo di Civitate 6
Turku 6
Wilmington 6
Amman 5
Baghdad 5
Brasília 5
Denver 5
Falkenstein 5
Haiphong 5
Hefei 5
London 5
Stockholm 5
Arezzo 4
Guangzhou 4
Lahore 4
Norwalk 4
Orem 4
Paris 4
Phoenix 4
Rio de Janeiro 4
Seattle 4
Tianjin 4
Ankara 3
Boston 3
Calgary 3
Canoas 3
Columbus 3
Curitiba 3
Erbil 3
Formia 3
Hải Dương 3
Istanbul 3
Montalto delle Marche 3
Poplar 3
Redwood City 3
Salvador 3
Tashkent 3
Tirana 3
Vicenza 3
Algiers 2
Aracaju 2
Asso 2
Baltimore 2
Baoding 2
Bexley 2
Bishkek 2
Biên Hòa 2
Bologna 2
Brooklyn 2
Campinas 2
Cape Town 2
Caracas 2
Totale 1.876
Salva come PNG Salva come JPEG
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 193
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer 128
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 120
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 119
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 112
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer 112
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 108
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 98
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 97
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients 96
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy 96
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 96
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer 94
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 93
Liquid Biopsy in early Breast Cancer: A preliminary Report 93
PD-L1 quantification across tumor types using the reverse phase protein microarray: Implications for precision medicine 89
Sensitivity to immune checkpoint blockade in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutations 85
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 84
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 84
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 84
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases 82
Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr 78
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer 77
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients 75
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 75
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer 73
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs 70
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations 69
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion 64
RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature 63
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 58
Totale 2.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022180 0 25 3 6 3 2 0 63 24 14 16 24
2022/2023438 21 84 5 54 39 30 0 21 163 3 15 3
2023/2024175 12 8 16 5 5 1 40 2 7 4 38 37
2024/2025502 7 35 42 16 54 41 14 42 81 45 75 50
2025/20261.259 76 87 67 162 184 104 218 70 139 109 30 13
2026/202750 22 28 0 0 0 0 0 0 0 0 0 0
Totale 2.865